Lutetium-PSMA therapy—a new therapeutic option in metastatic castration-resistant prostate cancer?
Crossref DOI link: https://doi.org/10.1007/s12254-018-0452-7
Published Online: 2018-11-06
Published Print: 2018-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ladurner, Michael http://orcid.org/0000-0003-2396-9175
Horninger, Wolfgang
Bektic, Jasmin
Text and Data Mining valid from 2018-11-06
Article History
Received: 18 June 2018
Accepted: 25 October 2018
First Online: 6 November 2018
Conflict of interest
: M. Ladurner, W. Horninger, and J. Bektic declare that they have no competing interests.